| Elizabeth Burgstahler, DMD | |
|
515 Delaware St Se # 6-240, Minneapolis, MN 55455-0357 | |
| (612) 625-6444 | |
| Not Available |
| Full Name | Elizabeth Burgstahler |
|---|---|
| Gender | Female |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 515 Delaware St Se # 6-240, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033789821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | R804 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Burgstahler, DMD 515 Delaware St Se # 6-240, Minneapolis, MN 55455-0357 Ph: () - | Elizabeth Burgstahler, DMD 515 Delaware St Se # 6-240, Minneapolis, MN 55455-0357 Ph: (612) 625-6444 |
News Archive
By Jan. 30, the state had enrolled 172,700 people, already surpassing its goal for April. But in Missouri, enrollment in the government health program has actually declined with state officials blaming error-ridden data from the federal exchange. Media outlets also follow developments in Arkansas and Nevada.
Zetiq Technologies Ltd., a subsidiary of Bio-Light Ltd., reports that it has fulfilled the essential requirements towards issuing a self declaration CE mark of conformity for its diagnostic product for identification of cervical cancer in cytological specimens.
Overeating has been found to impair blood sugar (glucose) control and insulin levels. A new study suggests that the duration of a bout of overeating can affect how the body adapts glucose and insulin processing when calorie intake increases.
Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced that it has enrolled the first patient in its European Phase 2 clinical trial evaluating WF10 as a treatment for allergic rhinitis.
› Verified 4 days ago
Dr. Brian J Chase, DMD Dentist Medicare: Medicare Enrolled Practice Location: 515 Delaware St Se, Minneapolis, MN 55455 Phone: 617-895-7348 | |
Dr. Jennifer Lynn Bonamici, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 515 Delaware St Se, Minneapolis, MN 55455 Phone: 612-625-5000 | |
Joanna Christine Bourain, DDS Dentist Medicare: Medicare Enrolled Practice Location: 1313 Penn Ave N, Minneapolis, MN 55411 Phone: 805-729-0090 | |
Dr. Michael W. Lehnert, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 515 Delaware St Se, 7th Floor, Mmhst, Minneapolis, MN 55455 Phone: 612-624-7133 Fax: 612-624-2669 | |
Luke Mcmahon, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 606 24th Ave S, Minneapolis, MN 55454 Phone: 612-659-8689 | |
Dr. Brett Andrew Voegele, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 515 Delaware St Se, 7th Floor, Moos Tower, Minneapolis, MN 55455 Phone: 612-624-8600 | |
Julio Sotillo Rodriguez, D.D.S., PH.D. Dentist Medicare: Medicare Enrolled Practice Location: 701 25th Ave S, Suite 400, Minneapolis, MN 55454 Phone: 612-625-3249 |